Successful repair of rupture #pararenal #aaa for failed #EVAR with @WLGore @WLGoreMedical #TAMBE transfemoral due to frozen shoulder and shaggy arch @UCSDsurgery
Andrew Barleben retweeted
Ingenuity in the Cath Lab. Endovascular Aortic Root Repair (Endo-Bentall) for Acute Type A Dissection. ahajournals.org/doi/abs/10.1… @Toursavadkohi @dr_ghoreishi #TAVR #TEVAR #Cardiotwitter #AHAJournals
Andrew Barleben retweeted
So honored to have worked on this issue with such an amazing and inspiring team 🥰🥳
No better way to kick off #WomenInMedicine month than by announcing that the @avsgjournal #OriginalWorkbyWomen issue is live.
38 articles with women first and last authors🤩.
Huge shoutout to the all-women editor team who curated this special issue 👏!
annalsofvascularsurgery.com/…
Andrew Barleben retweeted
If you knew and loved him, a GoFundMe has been set up to help his family with expenses:
gofund.me/a7796250
Andrew Barleben retweeted
UPDATE: Risk of Mortality Associated with Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease is No Longer Supported Based on Data and Analyses - Letter to Health Care Providers fda.gov/medical-devices/lett…
Andrew Barleben retweeted
📢Have you registered for the 2023 UCSF Vascular Symposium yet? Visit our website to register and view the fast-paced program including debates, interactive case discussions, and expert panels with an outstanding multi-disciplinary faculty. vascularsymposium.ucsf.edu/
Andrew Barleben retweeted
Fresh off the press. Our #HOPE team was invited to put together a step by step review of arterialization techniques. Open and endo are complimentary and each have their place. Read and share 🙏 doi.org/10.1016/j.jvscit.202… @JillSommerset @mattsmeds @hendolat @Vascupedia_com – at Houston, TX
Andrew Barleben retweeted
The Cook ZFEN+ IDE is approved by the FDA to start trial. Finally a tailored, patient specific fenestrated stent-graft to repair complex aortic aneurysms with more sealing, less compromise on vessel incorporation. It will expand indications of EVAR significantly! – at Houston, TX
Andrew Barleben retweeted
Replying to @VascularHaurani
@VascularHaurani @drseanlyden and PAC leaders Mark Mattos and @phcvascular - good policy and sustainable payment are critical to vascular surgeons and the @VascularSVS mission
Degradation of the safety net, increasing consolidation, rising inflationary costs, labor shortages… there IS MORE YOU CAN DO! #getinvolved #advocacy #VAM2023 @VascularSVS members YOU can make a difference vascular.org/advocacy
Andrew Barleben retweeted
Simultaneous #VAM23 presentation and @JVascSurg publication. What a great value add for @VascularSVS members and investigators.
Andrew Barleben retweeted
To everyone who will be at #VAM23 if you treat TBAD and have an opinion, idea, input, criticism, concern, question or just for “the love of the game”…join us next Friday 🙏 @KougiasP @ShereneShalhub @VascularSVS @MichaelSConteMD – at Houston, TX
Andrew Barleben retweeted
Apple Watch helps save woman’s life after collapsing in a hotel room from a ruptured aorta
#aorticaneurysm
9to5mac.com/2023/05/05/apple…
Andrew Barleben retweeted
70 years ago (May 6, 1953), Dr. John Gibbon used a heart-lung machine for the first time on an 18-year-old female ASD patient. A well-prepared giant achievement and the very begin of modern cardiac surgery! It also may remind us to foster innovation and allow disruptive ideas.
Congratulations and great work to Rohini Patel and @fallentineMS4 (who won’t be an MS4 forever) on their great presentations! Representing @UCSDsurgery at @VascularSocal!!! #scvss #scvss2023
Andrew Barleben retweeted
BASIL2 RCT paper now available on @TheLancet
Endovascular strategy superior for BTK lesions in terms of amputation free survival.
thelancet.com/journals/lance…













































